473 related articles for article (PubMed ID: 17163375)
1. [Surgical management of patients with peritoneal carcinomatosis of gastrointestinal origin].
Iesalnieks I; Kullmann F; Dahlke M; Ghali N; Agha A; von Breitenbuch P; Schoelmerich J; Schlitt HJ; Piso P
Z Gastroenterol; 2006 Dec; 44(12):1237-45. PubMed ID: 17163375
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal and gastrointestinal origin shows acceptable morbidity and high survival.
Hagendoorn J; van Lammeren G; Boerma D; van der Beek E; Wiezer MJ; van Ramshorst B
Eur J Surg Oncol; 2009 Aug; 35(8):833-7. PubMed ID: 19019619
[TBL] [Abstract][Full Text] [Related]
3. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Chua TC; Morris DL; Esquivel J
Ann Surg Oncol; 2010 May; 17(5):1330-6. PubMed ID: 20033321
[TBL] [Abstract][Full Text] [Related]
4. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
6. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
7. Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in management of peritoneal carcinomatosis from colorectal origin.
Ceelen WP
Surg Technol Int; 2005; 14():125-30. PubMed ID: 16525964
[TBL] [Abstract][Full Text] [Related]
8. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
[TBL] [Abstract][Full Text] [Related]
9. [Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal colorectal carcinomatosis: a newly validated standard whose contribution remains to be assessed].
Pocard M; Boige V
Bull Cancer; 2005 Feb; 92(2):151-4. PubMed ID: 15749644
[TBL] [Abstract][Full Text] [Related]
10. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].
Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P
Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282
[TBL] [Abstract][Full Text] [Related]
11. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis.
Franko J; Ibrahim Z; Gusani NJ; Holtzman MP; Bartlett DL; Zeh HJ
Cancer; 2010 Aug; 116(16):3756-62. PubMed ID: 20564081
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.
Ceelen WP; Peeters M; Houtmeyers P; Breusegem C; De Somer F; Pattyn P
Ann Surg Oncol; 2008 Feb; 15(2):535-41. PubMed ID: 17960463
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ; van Ruth S; de Bree E; van Sloothen GW; van Tinteren H; Boot H; Zoetmulder FA
J Clin Oncol; 2003 Oct; 21(20):3737-43. PubMed ID: 14551293
[TBL] [Abstract][Full Text] [Related]
17. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
18. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?
Yan TD; Morris DL
Ann Surg; 2008 Nov; 248(5):829-35. PubMed ID: 18948811
[TBL] [Abstract][Full Text] [Related]
19. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
20. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
